Joe and Bob Cardiovascular Webinar Series
ITS ALL ABOUT LOWERING LDL-C...
Are new LDL-C lowering drugs really needed?\
Background
Get the Bottom Line on cardiovascular meds from CU Pharmacy experts -- Drs. Joe Saseen and Robert Page. This webinar will compare and contrast new LDL-C lowering medications (including Evinacumab, Bempedoic acid, and Inclisiran). Cover the role of the new LDL-C lowering drugs in difficult to treat populations. Identify patients that are candidates for further LDL-C lowering despite maximally tolerated statin therapy.
Learning Objectives
- Compare and contrast new LDL-C lowering medications (including Evinacumab, Bempedoic acid, and Inclisiran).
- Delineate the role of the new LDL-C lowering drugs in difficult to treat populations.
- Identify patients that are candidates for further LDL-C lowering despite maximally tolerated statin therapy
About Joe and Bob
 Joseph Saseen PharmD
Associate Dean for Clinical Affairs and Professor, Department of Clinical Pharmacy. Joseph Saseen is Associate Dean for Clinical Affairs and Professor of Clinical Pharmacy and a Professor of Family Medicine. He also served as Vice Chair of the Department of Clinical Pharmacy for 10 years. Dr. Saseen has responsibilities for enhancing the school’s clinical enterprise, further developing sustainable clinical service models, and advocating for advancing the practice of pharmacy in the State of Colorado. He is a clinical pharmacist at the University of Colorado Health focusing on cardiovascular risk reduction and population health. Dr. Saseen teaches cardiovascular pharmacotherapy and other topics related to primary care, and is the PGY2 Ambulatory Care residency program director. His scholarly work includes almost 200 peer-reviewed publications and book chapters.
|  Robert Page II PharmD, MSPH, BCPS (AQ-cards), BCGP, FAHA, FHFSA, FCCP, FASHP
Professor, Departments of Clinical Pharmacy and Physical Medicine. Dr. Page, practices in Inpatient cardiology service and heart failure/transplant service at University Hospital, and serves on two committees of the American Heart Association where his contributions have demonstrated the expanse of drug knowledge that pharmacists bring to a multidisciplinary team. Dr. Page was recently awarded Excellence in Teaching from the University of Colorado Skaggs School of Pharmacy and the President's Teaching Award from University of Colorado.
|
CPE Accreditation
ITS ALL ABOUT LOWERING LDL-C... Are new LDL-C lowering drugs really needed?
UAN #0008-0000-21-105-H04-P/T, release: 10/06/2021, expiry 10/06/2024, 1.0 contact hours/0.1 CEU
The University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). This activity has been accredited for 1.0 contact hours of knowledge-based continuing pharmacy education. Participates will be provided instructions on how to claim CPE Credit after the webinar.
